2m 2m 2m 2m 2m 2m 2m
Cellectis Sp ADR (CLLS)
NASDAQ
$3.42+$0.01 (+0.41%)
Price as of Aug 21, 2026 7:18 PM EDT- $247.5MMarket Cap
- 19.47%1-Year Change
- BiotechnologyIndustry
Cellectis Sp ADR (CLLS)
$3.42+$0.01 (+0.41%)
CLLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.40 | ||
Change | -$0.07 (-1.87%) | ||
Open | $3.33 | ||
High | $3.48 | ||
Low | $3.20 | ||
Previous Close | $3.47 | ||
Volume | 26,655 | ||
30-Day Average Volume | 18,441 | ||
1-Week Change | 11.64% | ||
1-Month Change | 26.58% | ||
1-Year Change | 19.47% | ||
3-Year Change | 84.05% | ||
5-Year Change | -72.69% | ||
Fundamentals | |||
Shares Outstanding | 72.7M | ||
Total Assets | $324.7M | ||
Market Cap | $247.5M | ||
Enterprise Value | $186.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue